01 Identity and provenance
- Accepted binomial
- Nicotiana tabacum
- Common names
- Tobacco
- Family (APG IV)
- Solanaceae
- Part used
- Leaf
- Verification tier
- Tier 2 · Verified Clinical columns reviewed and a source is on record.
- Reviewer note (2026 audit)
- Ziska LH & Parks RM. Commun Med 2024;4:10.1038/s43856-024-00584-x | Gehlbach SH et al. JAMA 1974;229:1880-3 | VERIFIED 2026 (batch 3) - synthetic analogue, application, interactions, side effects and references populated from retrieved primary/regulatory sources. Interactions labelled CLINICAL vs THEORETICAL. Marketed-formulation column intentionally blank. | ROUTE
02 Constituent chemistry
| Chemical class | Marker compound | Synthetic analogue in use |
|---|---|---|
| Pyridine alkaloids | Nicotine
Leaf
|
Nicotine replacement products (patch, gum, lozenge) - nicotine is the compound itself. Varenicline and cytisine are partial nAChR agonists. |
The analogue column is what makes the interaction reasoning tractable: where a constituent has a marketed structural counterpart, the counterpart's interaction profile is the starting hypothesis for the plant.
03 Stated application
- Reported activity
- NO THERAPEUTIC USE of the plant. Isolated nicotine is used in smoking cessation. Listed here for occupational-health relevance.
- Reported adverse effects
- GREEN TOBACCO SICKNESS - acute nicotine poisoning from TRANSDERMAL absorption in harvesters handling wet uncured leaf. HIGHLY RELEVANT TO INDIAN AGRICULTURAL PRACTICE: prevalence has shifted to China, India and Brazil, with roughly 8 million affected worldwide including women and children; reported prevalence ranges from 0.08% to about 57% across studies. Nausea, vomiting, pallor, dizziness, headache, sweating, chills, abdominal pain, diarrhoea, salivation, weakness, breathlessness, hypotension. Risk rises with dew- or rain-wet leaf and with heat (increased surface blood flow). PREVENTION: washing with soap and water immediately after work removes about 96% of skin nicotine; avoid harvesting wet leaf.
04 Interaction matrix
Source column, verbatim: CLINICAL: additive with nicotine replacement therapy. Smoking induces CYP1A2 (a combustion effect, not a nicotine effect) - relevant to clozapine, olanzapine and theophylline dosing.
Normalised onto 2 canonical drug classes below.
Curated from the reviewed source
| Drug class | Severity | Mechanism type | Provenance | Expected effect | |
|---|---|---|---|---|---|
|
Narrow-therapeutic-index CYP3A4 substrates
Pharmacokinetic
|
4Contraindicated | PK-CYP3A4 | curated A | Toxic accumulation or subtherapeutic failure of the co-prescribed drug, s… | why ▾ |
Chemistry of this pair. Alkaloidal bases have pH-dependent absorption and commonly interact with hepatic CYP isoenzymes and efflux transporters. Class mechanism. Furanocoumarins, bergamottin, piperine, glabridin and berberine inhibit CYP3A4; hyperforin, andrographolide and several diterpenes induce it through PXR. Because CYP3A4 handles roughly half of marketed drugs, the affected list is broad and the direction is product-specific.
| |||||
|
Antipsychotics
CNS
|
3Major | PD-additive + PK-CYP | curated A | Extrapyramidal symptoms, QT prolongation, excess sedation, or loss of ant… | why ▾ |
Class mechanism. Additive dopaminergic blockade, QT prolongation and sedation, plus CYP1A2, 2D6 and 3A4 modulation of clozapine, risperidone and quetiapine exposure.
| |||||
Predicted from constituent chemistry
| Drug class | Severity | Mechanism type | Provenance | Expected effect | |
|---|---|---|---|---|---|
|
Antacids, PPIs and H2 blockers
Gastrointestinal
|
2Moderate | PK-absorption | predicted D | Reduced or erratic absorption of alkaloids; heartburn and reflux from pre… | why ▾ |
Chemistry of this pair. Alkaloidal bases have pH-dependent absorption and commonly interact with hepatic CYP isoenzymes and efflux transporters. Class mechanism. Gastric pH elevation alters the dissolution and ionisation of alkaloidal and enteric-coated botanical products; menthol- and peppermint-oil products lose their enteric protection at high pH and can be released prematurely.
| |||||
05 Hazard register
06 Confusable material
These entries could be mistaken for this one in trade, in the herbarium, or in a prescription. Powdered material is often indistinguishable, so the check is macroscopic, microscopic and chromatographic rather than nominal.
| Lobelia inflata
Indian Tobacco |
Campanulaceae | Shares the common name "tobacco" |
07 Mechanism map
Chemistry sorts to the left, pharmacology to the right. Dashed edges are predicted. Drag nodes, scroll to zoom, export at 3× for a figure.
08 Open literature
Abstract-scoped query built from this binomial, its common names and its marker compounds, run live against Europe PMC, PubMed and OpenAlex, then ranked locally against an evidence hierarchy.
09 Isomechanistic neighbours
Species whose interaction profile overlaps this one, ranked by shared severity weight rather than by count — a shared contraindication counts for more than a shared minor signal. Practical use: these are the plants you should not stack with this one, because the mechanisms summate.
| Species | Family | Shared classes | Weight | Jaccard |
|---|---|---|---|---|
| Atropa belladonna
Belladonna |
Solanaceae | 3 | 0.60 | |
| Hyoscyamus niger
Henbane |
Solanaceae | 3 | 0.60 | |
| Datura stramonium
Datura |
Solanaceae | 3 | 0.60 | |
| Mucuna pruriens
Mucuna |
Fabaceae | 3 | 0.60 | |
| Erythroxylum coca
Coca |
Erythroxylaceae | 3 | 0.60 | |
| Duboisia myoporoides
Corkwood |
Solanaceae | 3 | 0.50 |
10 References and notes
Source column: Fotedar S & Fotedar V. Indian J Occup Environ Med 2017;21:101-4. doi:10.4103/ijoem.IJOEM_160_17
Fotedar S & Fotedar V. Indian J Occup Environ Med 2017
21:101-4. doi:10.4103/ijoem.IJOEM_160_17
BibTeX for all 2 records
@article{FotedarS2017,
title = {Fotedar S & Fotedar V. Indian J Occup Environ Med 2017},
author = {Fotedar S},
year = {2017},
}
@article{anon,
title = {21:101-4. doi:10.4103/ijoem.IJOEM_160_17},
doi = {10.4103/ijoem.IJOEM_160_17},
}
Curator notes
No notes yet.
Sign in to add notes and save monographs.